Replies to post #9195 on Biotech Values

[DewDiligence]

Firmenich acquires SNMX for $1.50/sh in cash—a 43% premium to Friday’s close:

https://finance.yahoo.com/news/firmenich-acquire-senomyx-pioneer-taste-100000026.html

This is essentially a takeunder, despite the large premium relative to Friday close. SNMX is a onetime highflyer that fell onto hard times.